Imara Inc
Biotechnology
Healthcare
IMRA
26.29 M shares
NASDAQ US
traded
23 Feb 2023
listed
yes
open
5.21
52 week high
6.32
high
6.32
52 week low
1.32
low
5.18
growth
290.12 %
previous Close
5.45
P/E ratio
market cap
31.54 M
div yield
0
usd
Jun 2022
qoq
revenue
0.00 %
net incoming
-11.45 M
21.79 %
eps
0.00 %
20.99 %
eps surprise
13.73 %
net profit margin
-1144900000.00 %
0.00 %
operating incoming
-11.52 M
21.42 %
net change in cash
-6.05 M
48.83 %
cash on hand
30.43 M
-16.59 %
cost of revenue
0.00 %
top top